Lung Cancer Clinical Trials
Stacey Bledsoe, RN, director of diversity in clinical trials at Eli Lilly and Company, talks about the importance of diversity in clinical trials
Doctors all over the world conduct research studies known as clinical trials. More than 100 scientists and physicians, nurses, social workers and technologists at the IU Simon Comprehensive Cancer Center dedicate their professional lives to advancing cancer care through clinical trials. Learn more about clinical trials.
Below are lung cancer clinical trials. For questions, email either Maggie Uhrich, muhrich@iu.edu, or Lori Tyson, lotyson@iu.edu.
7 protocol(s) meet the specified criteria
CTO-BDX-CD-003OPEN TO ACCRUAL
A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules
CTO-IUSCCC-0770OPEN TO ACCRUAL
Serial Testing To Assess Cognitive Function In Patients With Cancer Being Treated With Immunotherapy
CTO-IUSCCC-0783OPEN TO ACCRUAL
Rapid ( Warm ) Autopsy Protocol for Patients with Small Cell Lung Cancer
CTO-LUNGMAPOPEN TO ACCRUAL
A MASTER PROTOCOL TO EVALUATE BIOMARKER-DRIVEN THERAPIES AND IMMUNOTHERAPIES IN PREVIOUSLY-TREATED NON-SMALL CELL LUNG CANCER (Lung-MAP Screening Study)
OTHN-IIR-IUSCC-0733OPEN TO ACCRUAL
Functional and Molecular Analysis of Muscle in Patients With and Without Head and Neck Cancer Cachexia
PULM-IIR-DRCOPEN TO ACCRUAL
Analysis of DRC in lung disease
RAON-IIR-IUSCC-0711OPEN TO ACCRUAL
Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients with Lung Tumors in Close Proximity to the Chest Wall
Web pages and graphics designed by Tyler Furman. Furman is a 2022 Herron School of Art + Design graduate.
